Skip to main content
Premium Trial:

Request an Annual Quote

IntegraGen, PICCOLO Researchers Collaborate to Validate Metastatic Colorectal Cancer Biomarker

NEW YORK (GenomeWeb) – IntegraGen said on Tuesday it is collaborating with researchers from the PICCOLO study to validate a microRNA biomarker as a predictor of progression-free survival in metastatic colorectal cancer patients treated with anti-EGFR therapy.

The PICCOLO study is a randomized clinical trial comparing Camptosar (irinotecan) alone to irinotecan combined with the anti-EGFR antibody Vectibix (panitumumab) in the treatment of 460 KRAS wild-type metastatic colorectal cancer patients who progressed after being given fluoropyrimidine treatment with or without Eloxatin (oxaliplatin).

The researchers initially reported in Lancet Oncology in July 2013 that there was no difference in overall survival between the two study arms, but individuals in the panitumumab group had "significantly" better progress-free survival, compared to the control group, IntegraGen said. In the collaboration, the French firm will investigate the expression levels of the oncology biomarker hsa-miR-31-3p in primary tumors from patients enrolled in the PICCOLO study with the goal of confirming the ability of the biomarker to predict patient outcomes, it said.

"Our objective with this research is to meet the need for selection biomarkers beyond the current reliance on KRAS and refine positive or negative selection biomarkers in prospective clinical trials analysis for making the best use of an effective targeted therapy for the benefit of the patients," Matthew Seymour, a professor of gastrointestinal cancer medicine at theUniversityofLeedsand chief investigator for the PICCOLO study, said in a statement.


The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.